Medical News

RSS

New report identifies enormous global impact of preterm birth and stillbirth

A new report issued today identifies the enormous global impact of preterm birth and stillbirth-and what can be done to decrease it. Globally, an estimated 13 million babies are born preterm each year. Newborn deaths now account for more than 42 percent of mortality in children under the age of five, a rise from 37 percent in the year 2000.

24 Feb 2010

QR Pharma awarded patent covering use of Posiphen and analogs in treatment of DS

QR Pharma, Inc., a developer of novel drugs to treat Alzheimer’s disease (AD), announced today that it was issued U.S. Patent No. 7,625,942, a "Method of Treating Down Syndrome" by the U.S. Patent and Trademark Office. The '942 patent covers use of Posiphen and analogs to treat cognitive impairments associated with Down Syndrome (DS). This patent valuably expands upon the original Posiphen and analog patent that claims composition of matter and use of compounds to lower amyloid-β precursor protein (APP) and thereby treat dementia and Alzheimer’s disease (AD).

24 Feb 2010

Elsevier shares internal custom publication guidelines with scientific and medical communities

Elsevier, the world's leading publisher of scientific, technical and medical (STM) information products and services announced today that it is publicly sharing its internal custom publication guidelines so that the scientific and medical communities can have insight into a new and practical set of publishing standards for producing custom and sponsored publications.

24 Feb 2010

BioStorage Technologies' Frankfurt facility receives green certification from ENTEGA Vertrieb

BioStorage Technologies, a worldwide provider of long- and short-term storage of biomaterials, sample management and cold chain logistics, today announced its full-service biorepository near Frankfurt, Germany received green certification from ENTEGA Vertrieb GmbH & Co., a leading Germany-based sustainable energy supplier.

24 Feb 2010

Updates on Carriage Services' investment profile

Carriage Services, Inc. today announced that it has updated its "Company & Investment Profile," which can be found on Carriage's website at http://www.carriageservices.com.

24 Feb 2010

Diabetic Neuropathy: Drug having disease-modifying potential will earn 40% patient share in the U.S

Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, for the treatment of diabetic neuropathy, a drug that has disease-modifying potential would earn 40 percent patient share in the U.S., according to surveyed U.S. neurologists. Similarly, in Europe, such a drug would earn a comparable patient share of 43 percent, according to surveyed European neurologists.

24 Feb 2010

Over-produced PKC-iota oncogene linked to poor pancreatic cancer patient survival

Researchers at the Mayo Clinic campus in Florida have found that PKC-iota (PKC), an oncogene important in colon and lung cancers, is over-produced in pancreatic cancer and is linked to poor patient survival. They also found that genetically inhibiting PKC in laboratory animals led to a significant decrease in pancreatic tumor growth and spread.

24 Feb 2010

AutoGenomics launches expanded test panel to detect 17 B-RAF mutations

AutoGenomics, a leader in providing automated, molecular testing solutions announced today that it has launched an expanded test panel to detect 17 B-RAF mutations for research use to enhance the understanding of B-RAF mutations.

24 Feb 2010

Prochymal achieves response rate of 63% when used as rescue therapy in children suffering from GvHD

Osiris Therapeutics, Inc. today reported that a new study shows Prochymal achieved an overall response rate of 63% when used as a rescue therapy in children suffering from severe treatment resistant graft vs. host disease (GvHD).

24 Feb 2010

Fresenius Medical Care fourth-quarter net revenue up 12%

Fresenius Medical Care AG & Co. KGaA, the world’s largest provider of dialysis products and services, today announced its results for the fourth quarter and full year of 2009.

24 Feb 2010

Consumer Watchdog calls for public release of Blue Cross premium hike investigation documents

Consumer Watchdog today condemned Blue Cross's transfer of $2.8 billion to its parent company since 2007, including approximately $719.5 million in 2009 alone, as a way of hiding its true financial condition from regulators scrutinizing steep rate hikes. Consumer Watchdog said Insurance Commissioner Steve Poizner should seize on the transfers to invalidate recent premium hikes and should make Blue Cross documents available for public scrutiny.

24 Feb 2010

PIA hails the elimination of medical malpractice insurers from draft of bill

The National Association of Professional Insurance Agents is hailing the elimination of medical malpractice insurers from the draft of a bill restricting the limited federal insurance antitrust exemption under the McCarran-Ferguson Act.

24 Feb 2010

Early implantation of cochlear devices in deaf children leads to better overall quality of life

Profoundly deaf children with cochlear implants to help them to hear rate their quality of life equal to their normal-hearing peers, according to new research from UT Southwestern Medical Center auditory specialists.

24 Feb 2010

Preliminary results of SonoSite's modified Dutch Auction tender offer announced

SonoSite, Inc., the world leader and specialist in hand-carried ultrasound for the point-of-care, today announced the preliminary results of its modified “Dutch Auction” tender offer which expired at 5:00 p.m. New York City time on February 19, 2010.

24 Feb 2010

New non-neurotoxic treatment for head lice in children

A new non-neurotoxic treatment for head lice has been found to have an average of 91.2% treatment success rate after one week, and to be safe in humans from six months of age and up. This is the finding of a study published today in Pediatric Dermatology.

24 Feb 2010

Phase III trial results of Osiris Therapeutics' Prochymal for GvHD to be presented at BMT Tandem Meeting

Osiris Therapeutics, Inc. today announced that results from the Phase III trial evaluating Prochymal for the treatment of steroid-refractory acute graft vs. host disease (GvHD) will be presented by Paul Martin, M.D., of the Fred Hutchinson Cancer Research Center and Paul Szabolcs, M.D., of Duke University Medical Center at the 2010 BMT Tandem Meeting. The meeting is being held February 24-28 in Orlando, Florida.

24 Feb 2010

Different rates of post-traumatic stress disorder in different countries: Study

A study published in the current issue of Psychotherapy and Psychosomatics provides new insights in the different rates of post-traumatic stress disorder that are found in studies performed in different countries.

24 Feb 2010

Health care reform legislation: Americans still split, but several provisions find wide support

The latest Kaiser Tracking Poll finds the public still split on health care reform legislation, with 43 percent in favor and 43 percent opposed. However, the poll also finds that majorities of Americans of all political leanings support several provisions in the health reform proposals in Congress and most attribute delays in passing the legislation to political gamesmanship rather than policy disagreements.

24 Feb 2010

Comparison study of two treatment strategies for severe sepsis reveals similar short-term survival rates

A comparison of two strategies for treating severe sepsis or septic shock finds that using lactate levels measured in blood samples showed a similar short-term survival rate compared to a treatment regimen using central venous oxygen saturation measured using a specialized catheter, according to a study in the February 24 issue of JAMA.

24 Feb 2010

Guardian offers six questions to help employees and their families avoid critical illness

If you want to protect your finances from the costs of heart disease, and keep your heart healthy, the experts at The Guardian Life Insurance Company of America, a leading provider of employee benefits, have compiled important questions that you should ask yourself before American Heart Month ends.

24 Feb 2010

Medical News

New report identifies enormous global impact of preterm birth and stillbirth

QR Pharma awarded patent covering use of Posiphen and analogs in treatment of DS

Elsevier shares internal custom publication guidelines with scientific and medical communities

BioStorage Technologies' Frankfurt facility receives green certification from ENTEGA Vertrieb

Updates on Carriage Services' investment profile

Diabetic Neuropathy: Drug having disease-modifying potential will earn 40% patient share in the U.S

Over-produced PKC-iota oncogene linked to poor pancreatic cancer patient survival

AutoGenomics launches expanded test panel to detect 17 B-RAF mutations

Prochymal achieves response rate of 63% when used as rescue therapy in children suffering from GvHD

Fresenius Medical Care fourth-quarter net revenue up 12%

Consumer Watchdog calls for public release of Blue Cross premium hike investigation documents

PIA hails the elimination of medical malpractice insurers from draft of bill

Early implantation of cochlear devices in deaf children leads to better overall quality of life

Preliminary results of SonoSite's modified Dutch Auction tender offer announced

New non-neurotoxic treatment for head lice in children

Phase III trial results of Osiris Therapeutics' Prochymal for GvHD to be presented at BMT Tandem Meeting

Different rates of post-traumatic stress disorder in different countries: Study

Health care reform legislation: Americans still split, but several provisions find wide support

Comparison study of two treatment strategies for severe sepsis reveals similar short-term survival rates

Guardian offers six questions to help employees and their families avoid critical illness

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News